Sign in to view content

Suprachoroidal CLS-TA Improves Patient Outcomes in Uveitis of All Anatomic Subtypes

Christopher R Henry, MD

Video
Published 2019

Christopher R. Henry, MD

Inflammatory and Infectious Diseases

Related

Suprachoroidally Injected CLS-TA in Uveitis Maintains Efficacy Outcomes Through 48 Weeks
Pauline T. Merrill, MD, FASRS
Annual Meeting Talks
2019
An analysis of the phase 2 trial with intraviteal aflibercept and suprachoroidal
Michael A. Singer, MD
Updates from the Field
2017
Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis following an Injectable Fluocinolone Acetonide Insert
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2020

Category: Inflammatory and Infectious Diseases

See more